Announcements Trials
Browse Landscape

Phase

Phase NA 2Phase 4 2Phase 2 2

Status

Completed 2

Sponsor Class

OTHER 2INDUSTRY 1

Study Type

Interventional 2

Sponsor

Cancer Type

Gastrointestinal 2

Conditions

Stomach Neoplasms 1Gastrointestinal Hemorrhage 1Dyspepsia 1Adenocarcinoma 1

Interventions

Dexamethasone 49Metformin 47Cyclophosphamide 42Saline Solution 38Cytarabine 34Sodium Chloride 32Bupivacaine 31Vincristine 27Cisplatin 26Propofol 25Methotrexate 25Letrozole 24Fluorouracil 24Dexmedetomidine 24Doxorubicin 23Fentanyl 22Carboplatin 22Etoposide 19Rituximab 18Morphine 18Bevacizumab 18Acetaminophen 18Lidocaine 17Granulocyte Colony-Stimulating Factor 17Prednisone 16Mercaptopurine 16Docetaxel 16Clomiphene 16Sevoflurane 15Ropivacaine 15

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 4 × OTHER × Rabeprazole × Clear all
NCT04697186 2023-01-31

Helicobacter Pylori Eradication With Berberine Plus Amoxicillin Triple Therapy Versus Bismuth-containing Quadruple Therapy

Xijing Hospital of Digestive Diseases

Phase 4 Completed
524 enrolled
Gastrointestinal

Dyspepsia, Stomach Neoplasms

NCT00844675 2012-10-18

Effects of Oral Rabeprazole on the Prevention of Ulcer Bleeding Following Endoscopic Mucosal Resection

The Catholic University of Korea

Phase 4 Completed
120 enrolled
Gastrointestinal

Adenocarcinoma, Gastrointestinal Hemorrhage

Data powered by HemOnc (CC BY 4.0) Colophon âš¡